Skip to main content
ImmuneCited

Determination of serum 25-hydroxyvitamin D levels in patients with alopecia areata and their comparison with levels in healthy controls: A cross-sectional study.

Felix Paolo J Lizarondo, Mia Katrina R Gervasio, Charmaine Vanessa S Chamberlin, Charissa Mia S Gnilo, Claudine Y Silva
Other JAAD international 2021 5 citations
PubMed DOI
<\/script>\n
`; }, get iframeSnippet() { const domain = 'immunecited.com'; const params = 'pmid\u003D34622224'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

Study Design

Study Type
Observational Study
Sample Size
29
Population
patients with vitamin d deficiency
Intervention
Determination of serum 25-hydroxyvitamin D levels in patients with alopecia areata and their comparison with levels in healthy controls: A cross-sectional study. 34.4%
Comparator
healthy controls
Primary Outcome
None
Effect Direction
Neutral
Risk of Bias
Unclear

Abstract

BACKGROUND: Alopecia areata (AA) has been postulated to be an autoimmune disease affecting the hair follicles. Because vitamin D receptors are present in the immune system and hair follicles, vitamin D has been hypothesized to affect the disease. OBJECTIVE: The aim of this study was to determine serum 25-hydroxyvitamin D levels and the percentage of vitamin D deficiency in AA patients and compare them with those in healthy controls in a Philippine tertiary hospital. METHODS: This cross-sectional study included 29 AA patients and 29 healthy controls. The serum 25-hydroxyvitamin D levels were determined using the chemiluminescent immunoassay method. RESULTS: There was no significant difference in the mean vitamin D levels between AA patients (24.41 ± 6.87 ng/mL) and healthy controls (24.68 ± 6.68 ng/mL) (P = .88). The percentage of patients with vitamin D deficiency, defined as <20 ng/mL, trended to higher among AA patients (34.4%) than among healthy controls (17.2%), with an odds ratio of 2.53 (95% CI 0.73-8.65), though this was not statsitically significant. LIMITATIONS: This study involved a limited number of patients in an urbanized area in the Philippines, and majority of the AA cases seen had mild AA. CONCLUSION: The trend toward the increased percentage of vitamin D-deficient individuals among AA patients seen in this study may provide insight into the association of vitamin D with AA.

TL;DR

The trend toward the increased percentage of Vitamin D-deficient individuals among AA patients seen in this study may provide insight into the association of vitamin D with AA.

Used In Evidence Reviews

Similar Papers